Toxic dermatosis
MONDO:001739620 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New drug could shorten hospital stays for rare drug reaction
Disease control Not yet recruitingThis Phase 2 trial tests whether adding benralizumab (a drug already used for asthma) to standard corticosteroid treatment can help people with DRESS syndrome recover faster and spend fewer days in the hospital. DRESS is a rare, severe allergic reaction to certain medications tha…
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Eye surgery breakthrough? tiny trial tests humira injection during corneal implant
Disease control Not yet recruitingThis early-stage trial will test whether injecting adalimumab (Humira) into the eye during Boston KPro surgery is safe for 8 patients with severe corneal damage. The study focuses on side effects and tolerability, not yet on how well it works. It is for people who have run out of…
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Simple DNA test could shield gout patients from deadly skin side effects
Prevention Not yet recruitingThis study tests whether a genetic test can prevent rare but severe skin reactions caused by the common gout drug allopurinol. About 228 Vietnamese adults with gout will either get the test before treatment or receive standard care. Those with a high-risk gene will take a differe…
Phase: PHASE4 • Sponsor: Haiphong University of Medicine and Pharmacy • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Which silver dressing heals wounds faster? new trial aims to find out
Symptom relief Not yet recruitingThis study compares a modern silver foam dressing to a traditional dry silver dressing for chronic wound infections. Researchers will track how much the wound shrinks in two weeks and how many wounds fully heal. The goal is to find which dressing works better and costs less for p…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC